Please login to the form below

Not currently logged in
Email:
Password:

Champix

This page shows the latest Champix news and features for those working in and with pharma, biotech and healthcare.

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’s Champix and GSK’s Zyban cleared of causing neuropsychiatric side effects

Pfizer’ s Champix and GSK’ s Zyban cleared of causing neuropsychiatric side effects. ... They also found that smokers treated with Champix had significantly higher quit rates than those treated with Zyban, nicotine patch or placebo.

Latest news

  • Study clears Pfizer’s Champix of serious risks Study clears Pfizer’s Champix of serious risks

    Study clears Pfizer’ s Champix of serious risks. Smoking-cessation drug 'does not increase risk' of depression or heart attacks. ... New research indicates Pfizer's stop-smoking drug Champix may not increase the risk of depression and heart attacks as

  • NICE and ABPI clash over access to medicines NICE and ABPI clash over access to medicines

    Pfizer's smoking cessation drug Champix (varenicline). • Merck &Co's Temodal (temozolomide) for newly diagnosed brain cancer in adults. •

  • PMEA 2009: Winners announced

    Finalist:. Title of Entry: Champix UK Team. Company: Pfizer UK. Finalist:. ... Title of Entry: CHAMPIX European Brand Team. Company: Pfizer. Finalist:. Title of Entry: The LIPITOR European Brand Team.

  • Data shows positive results for Champix

    Data shows positive results for Champix. Smokers who took Pfizer's Champix were more successful in quitting smoking and abstaining compared with those taking a placebo. ... Results from a new study show smokers who took Pfizer's Champix (varenicline)

  • FDA boxed warnings for Chantix and Zyban

    The US Food and Drug Administration (FDA) has announced a requirement for Pfizer and GlaxoSmithKline to put a boxed warning on the prescribing information for their smoking cessation drugs Chantix (Champix

More from news
Approximately 2 fully matching, plus 26 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Fendix

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics